Anaesthesia for endovascular management of cerebral aneurysms

European Journal of Anaesthesiology

Volumn 23, Issue 11, 2006, Pages 902-913

  Lakhani, S ^a   Guha, Arphan ^a   Nahser, H C ^a  

^a WALTON CENTRE FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Anaesthesia, general; Intracranial aneurysm; Stents, endovascular, intracranial; Subarachnoid haemorrhage

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; ALFENTANIL; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; ATRACURIUM; ATRIAL NATRIURETIC FACTOR; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DESMOPRESSIN ACETATE; ESMOLOL; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; MAGNESIUM; MANNITOL; MIDAZOLAM; MUSCLE RELAXANT AGENT; NIMODIPINE; OPIATE; OSMOTIC AGENT; OXYGEN; PAPAVERINE; PROPOFOL; REMIFENTANIL; SEVOFLURANE; TICLOPIDINE; UNINDEXED DRUG; VOLATILE AGENT;

ANESTHESIA INDUCTION; ANESTHESIOLOGICAL TECHNIQUES; ANESTHESIST; ANEURYSM RUPTURE; ANGIOPLASTY; ANTICOAGULANT THERAPY; ANTICOAGULATION; ANTIHYPERTENSIVE THERAPY; ARTIFICIAL VENTILATION; BLEEDING; BLOOD VOLUME; BRAIN ARTERY ANEURYSM; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN VASOSPASM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM EXAMINATION; CENTRAL NERVOUS SYSTEM; CENTRAL VENOUS PRESSURE; CLINICAL TRIAL; COMORBIDITY; CONFUSION; CRANIOTOMY; DIABETES INSIPIDUS; DISEASE EXACERBATION; DOPPLER ECHOGRAPHY; DRUG CONTRAINDICATION; ELECTROLYSIS; ELECTROLYTE BALANCE; ENDOTRACHEAL INTUBATION; ENDOVASCULAR SURGERY; GENERAL ANESTHESIA; HEMODILUTION; HUMAN; HYPERCAPNIA; HYPERTENSION; HYPOTENSION; HYPOVENTILATION; INAPPROPRIATE VASOPRESSIN SECRETION; INTERVENTIONAL RADIOLOGY; INTRACRANIAL HYPERTENSION; INTRAVENOUS ANESTHESIA; LUNG EDEMA; LUNG INSUFFICIENCY; MAINTENANCE THERAPY; MEDICAL PRACTICE; MENTAL DISEASE; MORBIDITY; NEUROLEPTANESTHESIA; NEUROLOGIC DISEASE; NEUROPHYSIOLOGY; NEURORADIOLOGY; OXYGEN THERAPY; POSTOPERATIVE ANALGESIA; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREMEDICATION; PREOPERATIVE CARE; PROTEIN BLOOD LEVEL; REVIEW; RISK REDUCTION; SEIZURE; SUBARACHNOID HEMORRHAGE; SURGICAL EQUIPMENT; SURGICAL RISK; SURGICAL TECHNIQUE; THROMBOEMBOLISM; THROMBOSIS; THROMBOSIS PREVENTION; TREATMENT INDICATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VASCULAR ACCESS; VASOSPASM;

ANESTHESIA; HUMANS; INTRACRANIAL ANEURYSM; MONITORING, PHYSIOLOGIC; PERIOPERATIVE CARE; PREOPERATIVE CARE; RADIOLOGY, INTERVENTIONAL; SUBARACHNOID HEMORRHAGE; VASCULAR SURGICAL PROCEDURES;

EID: 33750378062     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1017/S0265021506000901     Document Type: Review

References (107)

1. Rinkel GJ, Djibuti M, Algra A, Van Gijn J. Prevalence and risk of rupture of intracranial aneurysm: a systematic review. Stroke 1998; 29: 251-256.
2. Liebeskind DS. Cerebral aneurysms. Accessed on 23/01/2006, from http://www.emedicine.com/NEURO/topic503.htm
3. Poppen JL, Frager CA. Multiple intracranial aneurysms. J Neurosurg 1959; 16: 581-589.
4. Hop JW, Rinkel GJ, Algra A, van Gijn J. Case - fatality rates and functional outcome after subarachnoid haemorrhage: a systematic review. Stroke 1997; 28: 660-664.
5. Molyneux A, Kerr R, Yu L et al. International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping vs. Endovascular coiling in 2143 patients with intracranial aneurysms: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups and aneurysm occlusion. Lancet 2005; 366: 809-817.
6. Bracard S, Lebedinsky A, Anxionnat R et al. Endovascular treatment of Hunt and Hess grade IV and V aneurysms. Am J Neuroradiol 2002; 23: 953-957.
7. Serbinenko FA. Balloon catheterisation and occlussion of major cerebral vessels. J Neurosurg 1974; 41: 125-145.
8. Gugleilmi G, Vinuela F, Sepetka I et al. Electrothrombosis of saccular aneurysm via endovascualr approach: electrochemical basis, technique and experimental results. J Neurosurg 1991; 75: 1-7.
9. Guglielmi G, Vinuela F, Dionn J et al. Electrothrombosis of saccular aneurysms via endovascular approach. J Neurosurg 1991; 75: 8-14.
10. Drake C. Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg 1988; 68: 985-986.
11. Teasdale G, Drake CG, Hunt W et al. A universal subarachnoid haemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiat 1988; 51: 1457.
12. Jennett B, Teasdale G. Aspects of coma after severe head injury. Lancet 1977; i: 878-881.
13. Andreoli A, di Pasquale G, Pinelli G et al. Subarachnoid hemorrhage: frequency and severity of cardiac arrhythmias. A survey of 70 cases studied in the acute phase. Stroke 1987; 18: 558-564.
14. Brouwers PJAM, Wijdicks EFM, Hasan D et al. Serial electrographic recording in aneurysmal subarachnoid hemorrhage. Stroke 1989; 20: 1162-1167.
15. Di Pasquale G, Pinelli G, Andreoli A et al. Holter detection of cardiac arrhythmias in intracranial subarachnoid hemorrhage. Am J Cardiol 1987; 59: 596-600.
16. Galloon S, Rees GAD, Briscoe CE et al. Prospective study of electrocardiographic changes associated with subarachnoid hemorrhage. Br J Anaesth 1972; 44: 511-516.
17. Marion DW, Segal R, Thompson ME. Subarachnoid hemorrhage and the heart. Neurosurgery 1986; 18: 101-106.
18. Rudehill A, Olsson GL, Sundquist K et al. ECG abnormalities in patients with subarachnoid hemorrhage and intracranial tumors. J Neurol Neurosurg Psychiat 1987; 50: 1375-1381.
19. Vidal B, Dergal E, Cesarman E et al. Cardiac arrhythmias associated with subarachnoid hemorrhage: prospective study. Neurosurgery 1979; 5: 675-680.
20. Zaroff JG, Rordorf GA, Newell JB, Ogilvy CS, Levinson JR. Cardiac outcome in patients with subarachnoid haemorrhage and electrocardiographic abnormalities. Neurosurgery 1999; 44: 34-39.
21. Solenski NJ, Haley Jr EC, Kassell NF et al. Medical complications of aneurysmal subarachnoid hemorrhage: A report of the multicenter, cooperative aneurysm study. Crit Care Med 1995; 23(6): 1007-1015.
22. Kuroiwa T, Morita H, Tanabe H, Ohta T. Significance of ST segment elevation in electrocardiogram in patients with ruptured cerebral aneurysms. Acta Neurochir (Wien) 1995; 133: 141-146.
23. Kono T, Morita H, Kuroiwa T, Onaka H, Takatsuka H, Fujiwara A. Left ventricular wall motion abnormalities in patients with subarachnoid hemorrhage: neurogenic stunned myocardium. J Am Coll Cardiol 1994; 24: 636-640.
24. Davies KR, Gelb AW, Manninen PH, Boughner DR, Bisnaire D. Cardiac function in aneurysmal subarachnoid haemorrhage: a study of electrocardiographic and echocardiographic abnormalities. Br J Anaesth 1991; 67: 58-63.
25. Mayer SA, Fink ME, Homma S et al. Cardiac injury associated with neurogenic pulmonary edema following subarachnoid hemmorhage. Neurology 1994; 44: 815-820.
26. Parekh N, Venkatesh B, Cross D et al. Cardiac troponin I predicts myocardial dysfunction in aneurysmal subarachnoid hemorrhage. J Am Coll Cardiol 2000; 36: 1328-1335.
27. Diebert E, Barzilai B, Braverman A et al. The clinical significance of elevated troponin I in patients with nontraumatic subarachnoid hemorrhage. J Neurosurg 2003; 98: 741-746.
28. Baroldi G. Pathologic evidence of myocardial damage following acute brain injuries. In: DiPasquale G, Pinelli G, eds. Heart-Brain Interactions. New York, NY: Springer-Verlag, 1992: 43-47.
29. Kantor HL, Krishnan SC. Cardiac problems in patients with neurologic disease. Cardiol Clin 1995; 13: 115-121.
30. Eng CC, Lam AM. Cerebral aneurysms: anaesthetic considerations. In: Cottrell J, Smith D, eds. Anesthesia and Neurosurgery. St. Louis: Mosby, 1994: 376-405.
31. Jacob C, Kopelnik A, Fisher LA et al. Cardiac injury after subarachnoid hemorrhage is independent of the type of aneurysm therapy. Neurosurgery 2004; 55(6): 1244-1251.
32. Newton TR, Oman JK. Subarachnoid hemorrhage. Accessed on 26/01/2006, from http://www.emedicine.com/med/topic2883.htm
33. Tateish A, Sano T, Takeshita H, Suzuki T, Tokuno H. Effects of nifedepine on intracranial pressure in neurosurgical patients with arterial hypertension. J Neurosurg 1988; 69(2): 213-215.
34. Bell BA, Symon L. Smoking and subarachnoid haemorrhage. Br Med J 1979; 1: 577-578.
35. Knekt P, Reunanen A, Aho K et al. Risk factors for subarachnoid haemorrhage in a longitudinal population study. J Clin Epidemiol 1991; 44: 933-939.
36. Longstreth Jr WT, Nelson LM, Koepsell TD, van Belle G. Cigarette smoking, alcohol use, and subarachnoid haemorrhage. Stroke 1992; 23: 1242-1249.
37. Anderson CS, Feigin V, Bennett D, Lin RB, Hankey G, Jamrozik K. Active and passive smoking and the risk of subarachnoid haemorrhage. Stroke 2004; 35(3): 633-637.
38. Schievink WI, Wijdicks EF, Parisi JE, Piepgras DG, Whisnant JP. Sudden death from aneurysmal subarachnoid hemorrhage. Neurology 1995; 45: 871-874.
39. Simon RP. Neurogenic pulmonary edema. Neurol Clin 1993; 11(2): 309-323.
40. Naredi S, Lambert G, Eden E et al. Increased sympathetic nervous activity in patients with nontraumatic subarachnoid hemorrhage. Stroke 2000; 31: 901-906.
41. Drewes LR. Report of World Federation of Neurological Surgeons Committee on a universal subarachnoid haemorrhage grading scale. J Neurosurg 1988; 68: 985-986.
42. Claassen J, Vu A, Kreiter KT et al. Effect of acute physiologic derangements on outcome after subarachnoid hemorrhage. Crit Care Med 2004; 32(3): 832-838.
43. Maroon JC, Nelson PB. Hypovolaemia in patients with SAH: therapeutic implication. Neurosurgery 1979; 4: 223-226.
44. Kasuya H, Onda H, Yoneyama T, Sasaki T, Hori T. Bedside monitoring of circulating blood volume after subarachnoid haemorrhage. Stroke 2003; 34: 956-960.
45. Espiner A, Leikis R, Ferch R et al. The neuro-cardioendocrine response to acute subarachnoid haemorrhage. Clin Endocrinol 2002; 56: 629-635.
46. Godsiff LS, Matta BF. Intensive care management of intracranial haemorrhage. In: Matta BF, Menon DK, Turner JM, eds. Textbook of Neuroanaesthesia and Critical Care. London: Greenwich Medical Media, 2000: 329-341.
47. Diringer MN. Sodium disturbances frequently encountered in a neurologic intensive care unit. Neurol India 2001; 49: S19-S30.
48. van den Bergh WM, Algra A, van der Sprenkel JW, Tulleken CA, Rinkel GJ. Hypomagnesemia after aneurysmal subarachnoid hemorrhage. Neurosurgery 2003; 52: 276-282.
49. van den Bergh WM. Magnesium Sulfate in aneurysmal subarachnoid hemorrhage. A randomized controlled trial. Stroke 2005; 36: 1011-1015.
50. Juvela S. Plasma endothelin concentrations after aneurysmal subarachnoid haemorrhage. J Neurosurg 2000; 92: 390-400.
51. 2+ of N-methyl-D-aspartate activated channels. Biophysiol J 1990; 57: 1085-1090.
52. Rothman S. Synaptic release of excitatory amino acid neurotransmitter mediates anoxic neuronal death. J Neurosci 1984; 4: 1884-1891.
53. Young WL, Pile-Spellman J. Anaesthetic considerations for interventional neuroradiology. Anesthesiology 1994; 80: 427-456.
54. Recommendations of the International Commission on Radiological Protection. Elmsford, NY: Pergamon Press, 1991; 21: 1-25. ICRP publication 60.
55. Cardella J, Casarella W, DeWeese J et al. Optimal resources for the examination and endovascular treatment of the peripheral and visceral vascular systems. AHA Intercouncil Report on Peripheral and Visceral Angiographic and Interventional Laboratories. J Vasc Interv Radiol 2003; 14: S517-S530.
56. Manninen PH, Gignac EM, Gelb AW, Lownie SP. Anesthesia for interventional neuroradiology. J Clin Anaesth 1995; 7: 448-452.
57. Luginbuhl M, Remonda L. Interventional neuroradiology. Recent developments and anaesthesiologic aspects. Minerva Anesthesiol 1999; 65: 445-454.
58. Wang LP, Wolff J. Anesthetic management of severe chronic cardiopulmonary failure during endovascular embolisation of a PICA aneurysm. J Neurosurg Anesth 2000; 12: 120-123.
59. Manninen PH, Chan ASH, Papworth D. Conscious sedation for interventional neuroradiology: a comparison of midazolam and propofol infusion. Can J Anaesth 1997; 44: 26-30.
60. Qureshi AI, Suri MFK, Khan J et al. Endovascular treatment of intracranial aneurysms by using gugleilmi detachable coils in awake patients: safety and feasibility. J Neurosurg 2001; 94: 880-885.
61. Jones M, Leslie K, Mitchell P. Anaesthesia for endovascular treatment of cerebral aneurysms. J Clin Neurosci 2004; 11(5): 468-470.
62. Brilstra E, Rinkel G. Treatment of ruptured intracranial aneurysms by embolisation with controlled detachable coils. Neurologist 2002; 8: 35-40.
63. Hashimoto T, Gupta DK, Young WL. Interventional neuroradiology - anesthetic considerations. Anesthesiol Clin N A 2002; 20: 347-359.
64. Upadhyaya N, Sharma MR. Perioperative management of aneurysmal subarachnoid haemorrhage. J Neurosci 2004; 1: 21-25.
65. Lau K, Menon DK. Neurovascular anaesthesia and the management of ischaemic stroke. Anaesth Intens Care Med 2005; 6(5): 172-176.
66. Mee E, Dorrance D, Lowe D, Neil-Dwyer G: Controlled study of nimodipine in aneurysm patients treated early after subarachnoid hemorrhage. Neurosurgery 1988; 22: 484-491.
67. Ohman J, Heiskanen O. Effect of nimodipine on the outcome of patients after aneurysmal subarachnoid hemorrhage and surgery. J Neurosurg 1988; 69: 683-686.
68. Pickard JD, Murray GD, Illingworth R et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid hemorrhage. British aneurysm nimodipine trial. Br Med J 1989; 298: 636-642.
69. Manninen PH. Anesthesia outside the operating room. Can J Anaesth 1991; 38: R126-R129.
70. American Society of Anesthesiologists. Guidelines for nonoperating room anesthetizing locations. Approved by House of Delegates, October 1994. Park Ridge, IL: American Society of Anesthesiologists, 2000. Directory of Members, 2000: 491.
71. Jaeger K, Ruschulte H, Herzog T et al. Anaesthesiological and critical care aspects regarding the treatment of patients with arteriovenous malformations in interventional neuroradiology. Minim Invas Neurosur 2000; 43: 102-105.
72. Liem LK. Intraoperative neurophysiological monitoring. Accessed on 26/01/2006, from www.emedicine.com/neuro/topic102.htm
73. Liu AY, Lopez JR, Do HM, Steinberg GK, Cockroft K, Marks MP. Neurophysiological monitoring in the endovascular therapy of aneurysms. Am J Neuroradiol 2003; 24: 1520-1527.
74. Alexandrov AV, Joseph M. Transcranial Doppler: an overview of its clinical applications. Int J Emerg Intens Care Med 2000; 4(1): Accessed on 26/01/2006, from http://www. ispub.com/journals/IJEICM/vol4N1/tcd.htm
75. Tsementzis SA, Hitchcock ER. Outcome from 'rescue clipping' of ruptured intracranial aneurysms during induction of anaesthesia and endotracheal intubation. J Neurol Neurosurg Psychiat 1985; 48: 160-163.
76. Moss E. Volatile agents in neurosurgery. Br J Anaesth 1989; 63: 4-6.
77. Stephan H, Sonntag H, Schenk HD et al. Effects of disoprivan on cerebral blood flow, cerebral oxygen consumption, and cerebral vascular reactivity. Anaesthetist 1987; 36: 60-65.
78. Vandesteene A, Trempont V, Engelman E et al. Effect of propofol on cerebral blood flow and metabolism in man. Anaesthesia 1988; 43(Suppl): 42-43.
79. Hartung HJ. Intracranial pressure after propofol and thiopental administration in patients with severe head trauma. Anaesthetist 1987; 36: 285-287.
80. Ravussin P, Guinard JP, Ralley F et al. Effect of propofol on cerebrospinal fluid pressure and cerebral perfusion pressure in patients undergoing craniotomy. Anaesthesia 1988; 43(Suppl): 37-41.
81. Ravussin P, Templehoff R, Modica PA, Bayer-Merger MM. Propofol vs thiopental-isoflurane for neurosurgical anaesthesia: comparison of hemodynamics, CSF pressure and recovery. J Neurosurg Anaesth 1991; 3: 85.
82. Fox J, Gelb AW, Enns J, Murkin JM, Farrar JK, Manninen PH. The responsiveness of cerebral blood flow to changes in arterial carbon dioxide tension is maintained during propofol -nitrous oxide anaesthesia in humans. Anaesthesiology 1992; 77: 453.
83. Warner DS. Experience with remifentanil in neurosurgical patients. Anaesth Analg 1999; 89(Suppl 4): S33-S39.
84. Coles JP, Leary TS, Monteiro JN et al. Propofol anaesthesia for craniotomy: a double-blind comparison of remifentanil, alfentanil anf fentanyl. J Neurosurg Anaesth 2000; 12: 15-20.
85. Levy DM, Nowicki RWA. Anaesthesia for treatment of cerebral aneurysms. CPD Anaesth 2002; 4(3): 106-114.
86. Zander JF. Subarachnoid haemorrhage. Curr Opin Anaesth 1999; 12: 503-509.
87. Wang L, Popovic R. Anaesthetic management of subarachnoid haemorrhage. Accessed on 23/01/2006, from http://www.ctec.uwa.edu.au/anaesthesiawa/SAH.pdf
88. Lai YC, Manninen PH. Anaesthesia for cerebral aneurysms: a comparison between interventional neuroradiology and surgery. Can J Anaesth 2001; 48(4): 391-395.
89. Walker MB. Neurosurgical anaesthesia. Bulletin 3. Roy Coll Anaesth 2000; 3: 105-109.
90. Drummond JC, Patel PM. Neurosurgical anaesthesia. In: Cucchiara RF, Miller ED, Reves JG, Roizen MF, Savarese JJ, eds. Anesthesia. Philadelphia: Churchill Livingstone, 2000.
91. Turner J. Anaesthesia for neuroradiology. In: Matta B, Menon D, Turner J, eds. Textbook of Neuroaanesthesia and Critical Care. London, UK: Greenwich Medical Media, 2000.
92. Smith MJ, Le Roux PD, Elliott JP, Winn HR. Blood transfusion and increased risk for vasospasm and poor outcome after subarachnoid hemorrhage. J Neurosurg 2004; 101(1): 1-7.
93. Bendok B, Hanel R, Hopkins L. Coil embolisation of intracranial aneurysms. Neurosurgery 2003; 52: 1125-1130.
94. Torner JC, Nibbelink DW, Burmeister LF. Statistical comparisons of end results of a randomised treatment study. In: Sahs AL, Nibbelink DW, Torner JC, eds. Aneurysmal Subarachnoid Hemorrhage - Report of the Cooperative Study. Baltimore: Urban & Schwartzenberg, 1981: 249-275.
95. van Gijn J, Rinkel GJE. Subarachnoid haemorrhage: diagnosis, causes and management. Brain 2001; 124(2): 249-278.
96. Rinkel GJE, Feigin VL, Algra A, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage (Cochrane Review) 2004. The Cochrane Library; 4.
97. Murthy TVSP, Bhatia MP, Prabhakar T. Cerebral vasospasm: Aetiopathogenesis and intensive care management. Indian J Crit Care Med 2005; 9: 42-46.
98. Biondi A, Ricciardi GK, Puybasset L et al. Intra-arterial nimodipine for the treatment of symptomatic cerebral vasospasm after aneurismal subarachnoid hemorrhage: preliminary results. Am J Neuroradiol 2004; 25(6): 1067-1076.
99. Origitano TC, Wascher TM, Reichman H, Anderson DE. Sustained increased cerebral blood flow with prophylactic hypertensive hypervolaemic hemodilution ('triple-H therapy') after subarachnoid haemorrhage. Neurosurgery 1990; 27: 729-740.
100. Egge A, Waterloo K, Sjoholm H, Solberg, Tore I, Tor M. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid haemorrhage: a clinical, prospective, randomised, controlled study. Neurosurgery 2001; 49(3): 593-606.
101. Kim DH, Joseph M, Ziadi S, Nantes J, Dannenbaum M, Malkoff M. Increases in cardiac output can reverse flow deficits from a vasospasm independent of blood pressure: a study using xenon computed tomographic measurement of cerebral blood flow. Neurosurgery 2003; 53(5): 1044-1051.
102. Levy ML, Rabb CH, Zelman V, Giannotta SL. Cardiac performance enhancement from dobutamine in patients refractory to hypervolemic therapy for cerebral vasospasm. J Neurosurg 1993; 79: 494-499.
103. Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K. Superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm. J Neurosurg 1992; 77: 842-847.
104. Kassell NF, Helm G, Simmons N, Philips CD, Cail WS. Treatment of cerebral vasospasm with intraarterial papaverine. J Neurosurg 1992; 77: 848-852.
105. Clouston JE, Numaguchi Y, Zoarski GH, Aldrih EF, Simand JM, Zitnay KM. Intraraterial papaverine for cerebral vasospasm after subarachnoid hemorrhage. Am J Neuroradiol 1995; 16: 27-38.
106. Firlik KS, Kaufmann AM, Firlik AD, Jungreis CA, Yonas H. Intraarterial papaverine for the treatment of cerebral vasospasm following aneurysmal subarachnoid haemorrhage. Surg Neurol 1999; 51: 66-74.
107. Smith T, Enterkine D. Endovascular treatment of cerebral vasospasm. J Vascul Intervent Neuroradiol 2000; 11(5): 547-559.